141 related articles for article (PubMed ID: 6254121)
1. The relationship of the cyclic nucleotide system to inhibition of hepatic drug metabolism in Walker 256 carcinoma-bearing rats.
Olson JW; Weiner M
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):71-89. PubMed ID: 6254121
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatic drug metabolism in VX2 carcinoma-bearing rabbits.
Weiner M; Olson JW
Drug Metab Dispos; 1980; 8(3):139-42. PubMed ID: 6104575
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of Walker 256 carcinosarcoma cells growing subcutaneously, intramuscularly, or intraperitoneally on hepatic microsomal mixed-function oxygenase activity.
Sladek NE; Domeyer BE; Merriman RL; Brophy GT
Drug Metab Dispos; 1978; 6(4):412-7. PubMed ID: 28921
[TBL] [Abstract][Full Text] [Related]
4. Effects of parenteral and enteral hyperalimentation on hepatic drug metabolism in the rat.
Knodell RG; Steele NM; Cerra FB; Gross JB; Solomon TE
J Pharmacol Exp Ther; 1984 May; 229(2):589-97. PubMed ID: 6425494
[TBL] [Abstract][Full Text] [Related]
5. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
[TBL] [Abstract][Full Text] [Related]
6. Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats.
Farrell GC; Zaluzny L
Gastroenterology; 1983 Aug; 85(2):275-82. PubMed ID: 6862153
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
Budris DM; Yim GK; Schnell RC
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
[TBL] [Abstract][Full Text] [Related]
8. Altered distribution and excretion of N-1-methylnicotinamide in rats with Walker 256 carcinosarcoma.
Clark BR; Murai JT; Pomeranz A; Mills PA; Halpern RM
Cancer Res; 1975 Jul; 35(7):1727-33. PubMed ID: 236826
[TBL] [Abstract][Full Text] [Related]
9. Contrasting alterations in hepatic drug biotransformation of hexobarbital and p-chloro-N-methylaniline produced by prostaglandins.
Weiner M
Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):495-509. PubMed ID: 996362
[TBL] [Abstract][Full Text] [Related]
10. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
Proia AD; Edwards KD; McNamara DJ; Anderson KE
Gastroenterology; 1984 Apr; 86(4):618-26. PubMed ID: 6698363
[TBL] [Abstract][Full Text] [Related]
11. Relationships between chemotaxis, chemotactic modulators, and cyclic nucleotide levels in tumor cells.
Mokashi S; Delikatny SJ; Orr FW
Cancer Res; 1983 May; 43(5):1980-3. PubMed ID: 6299536
[TBL] [Abstract][Full Text] [Related]
12. Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion.
Guo WJ; Li J; Chen Z; Zhuang JY; Gu WH; Zhang L; Pang J; Lu CH; Zhang WZ; Cheng YF
Hepatogastroenterology; 2004; 51(56):381-6. PubMed ID: 15086165
[TBL] [Abstract][Full Text] [Related]
13. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma.
Kovach SJ; Price JA; Shaw CM; Theodorakis NG; McKillop IH
J Cell Physiol; 2006 Feb; 206(2):411-9. PubMed ID: 16110470
[TBL] [Abstract][Full Text] [Related]
14. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-arginine-enriched total enteral nutrition on body weight gain, tumor growth, and in vivo concentrations of blood and tissue metabolites in rats inoculated with Walker tumor in the kidney.
Gonzaga Silva LF; Odorico de Moraes M; Santos Dias Soares F; Mota Moura Fé D; Cavalcante JL; Anselmo JN; Leitao Vasconcelos PR
Nutrition; 2004 Feb; 20(2):225-9. PubMed ID: 14962691
[TBL] [Abstract][Full Text] [Related]
16. Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
Acco A; Alves da Silva MH; Batista MR; Yamamoto NS; Bracht A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):294-300. PubMed ID: 17910611
[TBL] [Abstract][Full Text] [Related]
17. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
Rikans LE; Notley BA
J Pharmacol Exp Ther; 1982 Mar; 220(3):574-8. PubMed ID: 7062268
[TBL] [Abstract][Full Text] [Related]
18. Drug metabolism in tumor-bearing rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of tumor-bearing rats.
Kato R; Takanaka A; Takahashi A; Onoda K
Jpn J Pharmacol; 1968 Jun; 18(2):224-44. PubMed ID: 4387084
[No Abstract] [Full Text] [Related]
19. Effect of hepatic microsomal mixed-function oxidase activities in rats pretreated with Nocardia rubra cell wall skeleton.
Iwasaki K; Noguchi H
Res Commun Chem Pathol Pharmacol; 1982 Aug; 37(2):267-77. PubMed ID: 7134631
[TBL] [Abstract][Full Text] [Related]
20. [Thiamine and pyruvate metabolism in tumor-bearing rats].
Velichko MG; Ostrovskiĭ IuM; Trebukhina RV
Vopr Med Khim; 1978; 24(2):220-4. PubMed ID: 664448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
